Live Quote · AMEXCANFHealthcare· Biotechnology

Can-Fite BioPharma Ltd.

$3.91 15.55%($-0.72)
TickerSpark Score
41/100
Weak
33
Valuation
40
Profitability
10
Growth
72
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CANF research report →

52-Week Range7% of range
Low
$2.56
Current
$3.91
High
$21.00
Company Overviewwww.canfite.com

About the company

Can-Fite BioPharma Ltd. , an Israeli clinical-stage biopharmaceutical company, specializes in the creation of small molecule therapeutic products. These treatments target a range of conditions including various cancers, inflammatory liver disorders, and erectile dysfunction.

CEO
Pnina Fishman
IPO
2012
Employees
5
HQ
Petah Tikva, IL

Price Chart

-81.02% · this period
$21.00$11.88$2.75Jul 02Dec 31Jul 02
Valuation
Market Cap
$2.10M
P/E
-886.66
P/S
26223.20
P/B
1191.10
EV/EBITDA
-1449.29
Div Yield
0.00%
Profitability
Gross Margin
100.00%
Op Margin
-1815.22%
Net Margin
-1794.62%
ROE
-141.01%
ROIC
-101.13%
Growth & Income
Revenue
$408.21K · -39.43%
Net Income
$-9,905,965 · -25.71%
EPS
$-12.03 · -1013.89%
Op Income
$-10,028,933
FCF YoY
-18.06%
Performance & Tape
52W High
$21.00
52W Low
$2.56
50D MA
$3.20
200D MA
$5.48
Beta
0.02
Avg Volume
1.85M

Get TickerSpark's AI analysis on CANF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 4, 26Farbstein Mottiother24,000
Jun 4, 26Fishman Pninaother24,000
Apr 25, 26Tamir Ilanother16,000
Mar 18, 26Regev Guyother0
Feb 8, 17Regev Guyother16
Jun 15, 20Regev Guyother200
Aug 1, 23Regev Guyother2,166
Aug 7, 24Regev Guyother2,166
Apr 25, 26Regev Guyother16,000
Jun 22, 21Bornstein Yosephother200
Coverage · CANF

Our CANF coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on CANF yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate CANF report →
Internal Compare

Similar companies

Peers in the same neighborhood.